Why Perform MSI Testing?
- Determine patient response to immunotherapy drugs.
- Screen for hereditary Lynch syndrome.
- Assess the risk of cancer recurrence.
Book MSI DNA Testing in Saudi Arabia | Lahalak Medical Platform
MSI testing is a vital molecular biomarker that identifies DNA mismatch repair deficiency, guiding personalized immunotherapy decisions and screening for Lynch syndrome to ensure the most effective oncological care.
Scientific name: Microsatellite Instability (MSI) Testing
An advanced molecular analysis measuring DNA sequence variations. It identifies mismatch repair deficiency to predict immunotherapy response and screen for hereditary cancer syndromes like Lynch syndrome.
Service type
Molecular analysis
Duration
3-7 business days
Fasting
Fasting is not required
Included Services
- Sample collection or biopsy receipt
- Advanced molecular laboratory analysis
- Detailed results report for the physician
Medical Service Information
Target Groups
- Colorectal cancer patients.
- Individuals with a strong family history of cancer.
- Solid tumor patients being considered for immunotherapy.
Expected Results
- MSI-High: Indicates a likely positive response to immunotherapy.
- MSS (Stable): Indicates microsatellite stability and a different treatment path.
Conditions & Notices
- Medical history and physician report preferred
- The test may require a tumor tissue sample
Medical services you might also like
